PTC Therapeutics, Inc. announced it has entered into an asset purchase agreement with Marathon Pharmaceuticals, LLC to acquire all rights...
The FDA has approved Emflaza (deflazacort) tablets and oral suspension, from Marathon Pharma, to treat patients age 5 years and...